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Functional consequencesof sphingomyelinase-induced
changes in erythrocyte membrane structure
S Dinkla1,2,6, K Wessels1,6, WPR Verdurmen1, C Tomelleri3, JCA Cluitmans1, J Fransen4, B Fuchs5, J Schiller5, I Joosten2, R Brock1
and GJCGM Bosman*,1
Inflammation enhances the secretion of sphingomyelinases (SMases). SMases catalyze the hydrolysis of sphingomyelin into
phosphocholine and ceramide. In erythrocytes, ceramide formation leads to exposure of the removal signal phosphatidylserine
(PS), creating a potential link between SMase activity and anemia of inflammation. Therefore, we studied the effects of SMase on
various pathophysiologically relevant parameters of erythrocyte homeostasis. Time-lapse confocal microscopy revealed a
SMase-induced transition from the discoid to a spherical shape, followed by PS exposure, and finally loss of cytoplasmic
content. Also, SMase treatment resulted in ceramide-associated alterations in membrane–cytoskeleton interactions and
membrane organization, including microdomain formation. Furthermore, we observed increases in membrane fragility,
vesiculation and invagination, and large protein clusters. These changes were associated with enhanced erythrocyte retention in
a spleen-mimicking model. Erythrocyte storage under blood bank conditions and during physiological aging increased the
sensitivity to SMase. A low SMase activity already induced morphological and structural changes, demonstrating the potential of
SMase to disturb erythrocyte homeostasis. Our analyses provide a comprehensive picture in which ceramide-induced changes
in membrane microdomain organization disrupt the membrane–cytoskeleton interaction and membrane integrity, leading to
vesiculation, reduced deformability, and finally loss of erythrocyte content. Understanding these processes is highly relevant for
understanding anemia during chronic inflammation, especially in critically ill patients receiving blood transfusions.
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During their stay in the circulation forB120 days, erythrocytes
undergo age-related changes involving senescent cell anti-
gen formation, cell shrinkage, vesiculation, and loss of
deformability. The binding of autologous IgG and exposure
of recognition molecules, possibly including phosphatidylser-
ine (PS), ultimately lead to recognition of senescent erythro-
cytes by macrophages of the reticulo-endothelial system.1
Also, the deformability of the erythrocyte constitutes an
important survival parameter, as splenic sequestration of
abnormal erythrocytes with reduced deformability leads to a
decreased erythrocyte life span and anemia in several
erythrocyte membranopathies.2
Chronic inflammation, as occurring in various pathological
conditions, is associated with anemia and poor disease
outcome.3 This inflammation-driven anemia is especially
troublesome in patients with severe sepsis. Furthermore,
blood transfusions to counter sepsis-induced anemia only
have a limited beneficial effect, and may lead to severe
complications.4 Reduced erythrocyte production can only
partly explain the low erythrocyte count. Enhanced erythro-
cyte clearance is likely to contribute to the anemia, but its
causes are largely unknown.5 Therefore, understanding the
underlyingmechanisms of anemia of inflammation is of critical
importance.
Inflammation triggers the secretion of acid sphingomyeli-
nase (SMase), which is involved in various pathologies,
including diabetes, sepsis, cardiovascular and pulmonary
diseases.6 SMases catalyze the hydrolysis of sphingomyelin
(SM), a major lipid component of cell membranes, into
phosphocholine and ceramide.7 Ceramide functions as a lipid
second messenger in many cellular processes including
apoptosis, senescence and inflammation, which is partially
explained by the tendency of signaling receptors to cluster in
ceramide-enriched platforms.8,9 Also, the formation of these
rigid platforms alters membrane curvature and decreases
plasma membrane integrity.7,10
Although erythrocytes do not possess SMase activity of
their own,11 and SMases have not been reported as part of the
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erythrocyte proteome,12 erythrocytes can be exposed to
SMase secreted by vascular endothelium, leukocytes, and
platelets.6 SMase treatment and direct ceramide incorpora-
tion into erythrocytes induces PS exposure.13–15 Also,
erythrocytes expose PS and ceramide after incubation with
SMase-containing plasma of patients suffering from sepsis or
Wilson’s disease.16,17 So far, however, only PS exposure and
size have been studied. Pathophysiologically relevant mole-
cular processes on the membrane and protein level and their
association with functionally relevant parameters have not
been addressed as yet.
In the current study, we comprehensively addressed the
changes that erythrocytes undergo with respect to morphol-
ogy, deformability, membrane lipid organization, and protein–
protein interactions upon exposure to SMase. Time-lapse
microscopy revealed that SMase-driven PS exposure pre-
cedes loss of membrane integrity. We also demonstrate a
clear erythrocyte age-related increase in sensitivity to SMase,
both in erythrocytes from freshly drawn blood and from blood
bank units. Next to PS exposure as a critical removal signal,
enhanced vesiculation, which is associated with several
erythrocyte-associated pathologies,18 was observed. These
findings reveal SMase-induced ceramide formation as a
critical event in erythrocyte membrane reorganization on both
the lipid and protein level, and provide a possible explanation
for the reduced effectiveness and harmful side effects of
erythrocyte transfusion in patients with sepsis.
Results
SMase alters erythrocyte morphology and increases PS
exposure. Secretion of SMase is enhanced during inflam-
mation and involved in the pathophysiology of various
diseases.6 As SMase-induced ceramide formation changes
membrane lipid organization, enhanced SMase activity could
also affect erythrocyte physiology including deformability and
exposure of removal signals such as PS, thereby explaining
excessive erythrocyte clearance in anemia of inflammation.
This hypothesis is supported by the observation that plasma
of septic patients induced ceramide formation and PS
exposure on the erythrocyte membrane.16
To determine the sensitivity of erythrocytes to SMase,
erythrocytes were incubated with ascending activities of
SMase and analyzed by flow cytometry. Bacterial SMase
was used as a valid surrogate for acid and neutral SMase
encountered by erythrocytes in vivo.19 Cytoplasmic proteins
were labeled by incubation with membrane-permeable
carboxyfluorescein succinimidyl ester diacetate (CFSE dia-
cetate). In this way, a potential loss of membrane integrity was
detectable through loss of fluorescence from the cytoplasm.
Erythrocyte size, as reflected by forward scatter, signifi-
cantly decreased already at 1mU/ml, with a further reduction
in size and a high increase in PS exposure at activities of
10mU/ml and higher (Figures 1a–c). Also, the asymmetric
shape of the forward-versus-sideward scatter plot of the
erythrocyte population was lost upon treatment, suggesting
that the cell shape was affected (Figure 1a). The sideward
scatter increased, which is indicative of the degree of cell
granularity. In the absence of extracellular calcium during 10
and 100mU/ml SMase treatment PS exposure was not
induced (0.92% and 0.72% respectively), suggesting the
involvement of a calcium-activated scramblase in this
process.20
Although the flow cytometry analyses provided information
on the erythrocyte population at a fixed time point, time-lapse
confocal laser scanning microscopy revealed a characteristic
sequence of events upon SMase treatment: first, erythrocytes
lost their discoid shape, which was followed by a gradual
increase in the percentage of PS-exposing cells (Figure 1d
and Supplementary Movie S1). Subsequently, some erythro-
cytes lost their cellular content, as indicated by the loss of the
CFSE signal. After 45min of SMase treatment, a considerable
part of the cells had an irregular membrane surface, as
observed by bright-field microscopy (Supplementary Figure
S1). Intriguingly, most of these cells showed high-intensity
CFSE spots, which colocalized with the membrane irregula-
rities (Supplementary Figure S1). These clusters are most
likely large protein clusters, as CFSE covalently binds to
proteins. Furthermore, only a few of the irregularly shaped
cells exposed PS, as compared with the spherical cells with a
smooth surface and high PS exposure (Supplementary Figure
S1 and Supplementary Movie S1).
SMase specifically hydrolyzes SM in erythrocytes. To
confirm enzyme specificity and to estimate the extent of SM
breakdown and ceramide formation, lipid analyses were
performed on the membrane fractions of erythrocytes treated
with various SMase activities.
Consistent with the expected activity of SMase, positive-ion
matrix-assisted laser desorption and ionization time-of-flight
(MALDI-TOF) mass spectrometry (MS) revealed the pre-
sence of ceramide and absence of SM in membrane lipid
fractions of 10 and 100mU/ml SMase-treated erythrocytes
(Figure 2a). In controls and 1mU/ml-treated cells, no
ceramide was detected. Apparently, at 1mU/ml concentration
the extent of ceramide formation was below the detection limit
of this method. Alternatively, the small amount of ceramide
might have been suppressed by more abundant lipids, such
as phosphatidylcholines (PCs).21 We were not able to detect
ceramide subsequent to analysis by combined thin-layer
chromatography/MALDI as previously described.22 However,
after 1 and 5mU/ml SMase treatment the percentage of cells
with ceramide-enriched platforms was increased, as detected
by immunofluorescence (see below). This is a strong
indication that the amount of the generated ceramide at
1mU/ml SMase is beyond the detection limit of MS. 31P
nuclear magnetic resonance (NMR) spectroscopy confirmed
the nearly complete disappearance of SM after 100mU/ml
SMase treatment of erythrocytes, while the major membrane
phospholipids phosphatidylethanolamine (PE), PC and PS
were not affected (Figure 2b). Thus, the used enzyme
preparation specifically hydrolyzed SM in the erythrocyte
plasma membrane.
SMase-induced erythrocyte membrane reorganization.
The changes in erythrocyte morphology, PS externalization,
and ceramide formation, suggest that SMase induces major
membrane reorganization. This reorganization was studied in
more detail using electron microscopy and confocal laser
scanning microscopy.
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Consistent with our observations by confocal microscopy,
electron microscopy also showed an SMase treatment-
induced loss of the typical biconcave shape (Figure 3a).
A striking finding was the presence of structures resembling
intracellular membrane vesicles, or endovesicles, in the
SMase-treated erythrocytes. In most cells these structures
were confined to one side of the cell in one large cluster.
We also investigated the presence of microdomains in
SMase-treated erythrocytes.23 In untreated erythrocytes, the
glycosyl phosphatidylinositol-anchored microdomain marker,
CD59,24 was distributed evenly over the erythrocyte mem-
brane (Figure 3b). SMase treatment at activities of 1mU/ml
and higher induced CD59 clusters that colocalized with the
membrane irregularities observed in the bright-field images
(Figure 3b).
SMase-treated erythrocytes were also stained for stomatin,
which is anchored at the cytoplasmic side of the membrane
and is associated with lipid rafts in erythrocytes.25 The
findings with stomatin were similar to those obtained with
CD59, althoughmany additional small clusters were observed
upon SMase treatment (Figure 3d). Moreover, a combined
staining for stomatin and band 3, which is an abundant
erythrocyte membrane protein involved, among others, in
linking the plasma membrane to the cytoskeleton, revealed
the presence of tubular plasma membrane invaginations in
cross-sections of a subpopulation of the SMase-treated
erythrocytes (Figure 3d, right-most images and Figure 3e).26
The tubular invaginations also colocalized with membrane
irregularities seen in bright field. A three-dimensional recon-
struction and animation showing these invaginations is
provided in the Supplementary Data (Supplementary Movies
S2 and S3).
Finally, anti-ceramide antibody staining revealed the pre-
sence of ceramide-enriched platforms on SMase-treated
Figure 1 Erythrocyte shape and PS exposure during SMase treatment. (a–c) Flow cytometry of erythrocytes treated with increasing activities of SMase for 15 min at
37 1C. Annexin V-FLUOS staining was performed to determine the percentage of PS-exposing erythrocytes. (a) Forward and sideward scatter (FSC and SSC, respectively)
density plots are presented. (b and c) The graphs represent mean values of three healthy volunteers; error bars represent S.D.; *Po0.05. (d) Time-lapse confocal laser
scanning microscopy of CFSE-labeled erythrocytes treated with 10 mU/ml SMase at 37 1C in the presence of Annexin V-Alexa 647. Confocal laser scanning microscopy was
used to image fluorescence as described in Materials and Methods. Scale bar¼ 5 mM. A typical result from one of three experiments is presented
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erythrocytes (Figure 3f). It is noteworthy that following acrolein
fixation seven to eight times more positive events were
detected (after correction for isotype control) than following
paraformaldehyde fixation. The recognition of ceramide on
only a subpopulation of the cells after 5mU/ml SMase
treatment and the high dependence of antibody binding on
Figure 2 Erythrocyte membrane lipid analyses after SMase treatment. Erythrocytes were treated with SMase for 1 h at 37 1C. (a) Positive-ion MALDI-TOF MS of isolated
membrane lipids. All samples were 1:1 (v/v) diluted with the matrix (0.5 M 2,5-dihydroxybenzoic acid in methanol). All peaks are labeled based on their m/z ratios and matrix
cluster ions are marked by an asterisk.39 (b) 31P NMR spectra of membrane lipid extracts. All samples were investigated in the presence of 200 mM sodium cholate to suppress
the aggregation of phospholipids.40 Cer, ceramide
SMase-induced changes in erythrocyte function
S Dinkla et al
4
Cell Death and Disease
the fixative used suggest that the specificity and activity of this
antibody is strongly affected by membrane organization.
Next, we investigated whether SMase-induced membrane
reorganization also affected the interaction between the
plasma membrane and the cytoskeleton. Differential mem-
brane protein extraction showed that the insoluble fraction of
band 3 increased upon SMase treatment (Supplementary
Figure S2). In contrast, the extractability of b-actin with
detergent increased upon SMase treatment. These changes
implicate that in addition to the membrane microdomain
organization at the protein and lipid levels, the cytoskeletal
integrity and the interaction between plasma membrane and
cytoskeleton are also altered by SMase.
SMase enhances erythrocyte vesicle formation. During
aging, the erythrocyte produces numerous vesicles that
Figure 3 SMase-induced erythrocyte morphology, membrane lipid rafts, and intracellular invaginations. SMase treatment of erythrocytes was performed for 15 min at
37 1C. (a) Electron microscopy of control and SMase-treated erythrocytes as described in Materials and Methods. (b) Erythrocytes stained with an anti-CD59 antibody.
(c) Quantification of CD59 cluster-positive erythrocytes. The graph presents mean values (N¼ 2), error bars represent S.D. Two-hundred cells were scored by eye per
experiment. (d) Acrolein-fixed erythrocytes stained with anti-stomatin (green) and anti-band 3 (red) antibodies. (e) Z-stack of an anti-stomatin-stained, tubulated, erythrocyte
after treatment with 10 mU/ml SMase. A Z-slice spacing of 0.25mM was used. (f) Flow cytometry and confocal microscopy of erythrocytes treated with 5 mU/ml SMase, stained
with anti-ceramide or isotype control antibody. Confocal laser scanning microscopy was used to image fluorescence as described in Materials and Methods. Bright-field
images are shown in combination with fluorescence images. Signal intensity in b and e: low¼ blue, intermediate¼ red, and high¼ yellow/white. Scale bar¼ 5 mM.
Representative images from one of two experiments are shown in all cases
SMase-induced changes in erythrocyte function
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expose removal signals including PS, that are enriched in
damaged membrane patches, and are rapidly removed from
the circulation. Physiologically, erythrocyte vesiculation may
constitute a protective mechanism to prevent untimely
erythrocyte removal.27 Increased erythrocyte vesicle num-
bers were observed in several inflammation-associated
diseases, including chronic renal failure, sickle cell disease,
and b-thalassemia.18 Therefore, we investigated whether
erythrocyte vesiculation rate and vesicle composition are
affected by SMase treatment.
Erythrocytes were allowed to vesiculate in vitro in the
presence or absence of SMase. The vesicles generated
in vitro and the plasma vesicles from the corresponding
healthy volunteers were assessed for PS exposure and the
presence of the erythrocyte-specific marker glycophorin A
(CD235a). Erythrocyte-derived plasma vesicles, control vesi-
cles generated in vitro, and vesicles from SMase-treated
erythrocytes all exposed PS and expressed CD235a
(Figure 4a). Plasma vesicles and control vesicles formed a
single population with a comparable, high PS exposure and
CD235a expression. An additional population with clearly
reduced PS exposure and CD235a expression was observed
in the SMase-induced vesicles (Figures 4a and b). In contrast,
glycophorin C expression was found to be identical in all
conditions (data not shown). On the basis of the forward
scatter, all PSþCD235aþ vesicles had similar dimensions
(Figure 4b). In addition to these qualitative differences
between control and SMase-induced vesicles erythrocyte,
vesiculation was enhanced more than 20-fold when the cells
were exposed to SMase (Figure 4c). This heterogeneity in PS
exposure and CD235a expression indicates that SMase-
induced vesiculation differs qualitatively from vesiculation in
the absence of SMase. Finally, CFSE-loaded erythrocytes
generated CFSE-positive vesicles during SMase treatment
(Figure 4d), showing that these vesicles contain cytoplasmic
content of the parent cells.
Loss of osmotic responsiveness in erythrocytes treated
with SMase. Following the analysis of the impact of SMase
treatment on the structural organization of erythrocytes, we
were interested in potential functional implications of SMase
exposure. In the circulation, erythrocytes are constantly
exposed to changing osmolalities, in particular when passing
through the kidneys, and osmotic stress is known to induce
PS exposure.28 To study the effect of SMase on the osmotic
responsiveness and fragility of erythrocytes, SMase-treated
erythrocytes were exposed to different osmolalities and
analyzed by flow cytometry.
When erythrocytes were treated with SMase activities of
1mU/ml and higher, a population could be discerned with a
low sideward scatter that was not seen in control erythrocytes
(Figure 5). These populations had a nearly identical CFSE
content and forward scatter, indicating that they had intact
membranes and were of comparable size. When exposed to a
hypertonic or hypotonic buffer, the SMase-treated erythro-
cytes with a normal sideward scatter and the control
erythrocytes shrank and swelled, respectively (Figure 5). In
contrast, the size of the additional population in the SMase-
treated erythrocytes did not change upon incubation with
these buffers, indicating a loss of osmotic responsiveness.
When erythrocytes were treated with higher (Z10mU/ml)
SMase activities and subsequently incubated in hypotonic
buffer, nearly all cells, including this additional population,
were lysed, showing an SMase-induced increase in mem-
brane fragility (Figure 5).
SMase enhances erythrocyte retention in a spleen-
mimicking model. Sequestration of poorly deformable
erythrocytes by the spleen is known to be critically involved
in the decreased erythrocyte life span and anemia in several
erythrocyte disorders.2 The observed changes in erythrocyte
morphology, ceramide formation, and membrane organiza-
tion upon SMase treatment, likely also affect erythrocyte
deformability. To determine whether SMase treatment
affected deformability and splenic retention, we used a
bead-sorting device that mimics the mechanical deformation
that erythrocytes experience in the spleen.
Erythrocytes were treated with SMase for 15min at 37 1C,
labeled with CFSE and perfused through the spleen-mimick-
ing model. Treatment with SMase induced a decrease in the
permeation of themodel spleen, concomitant with an increase
in the retention (Figure 6). As before, SMase treatment
reduced erythrocyte size, as reflected by forward scatter
(Figure 6).
Age and storage of erythrocytes increase their sensitiv-
ity to SMase. Erythrocytes become more sensitive to
stressors such as energy depletion and hyperosmotic
conditions with age and storage time.28–30 As SMase plasma
levels increase during inflammation, and critically ill patients
often receive erythrocyte transfusions, the sensitivity of
stored erythrocytes for SMase-induced changes in cell size
and PS exposure were studied by flow cytometry.
Erythrocytes from six healthy donors were obtained
immediately after donation, and after 14 and 35 days of
storage under blood bank conditions. After incubation with
1mU/ml SMase for 15min at 37 1C, we observed amuchmore
pronounced size reduction and increase in PS exposure for 35
day-stored erythrocytes, compared with fresh and 14 day-
stored cells (Figure 7a).
As erythrocyte age might also affect the response to
SMase-induced ceramide formation in the plasmamembrane,
a combination of volume and density separation was used to
obtain well-defined erythrocyte populations of different mean
age. These were treated with 1 and 10mU/ml SMase, and
showed an age-dependent increase in the sensitivity for
SMase-induced PS exposure (Figure 7b).
Discussion
The chronic inflammation that arises in patients with various
diseases, including sepsis, can induce anemia, which is
associated with poor disease outcome.3 Inflammation
enhances SMase secretion, and ceramide formation and
PS exposure were observed when erythrocytes were
incubated with plasma from septic patients ex vivo.16 PS
exposure is a marker for cellular stress and contributes to
erythrocyte removal.31 So far, studies concerning SMase
activity on erythrocytes focused on membrane lipid rearran-
gement and shape changes.13,32 In this study we show that
SMase-induced changes in erythrocyte function
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ceramide-induced membrane lipid rearrangement affects
multiple processes that are critical for erythrocyte func-
tion and removal, including protein–protein interactions,
membrane stability, and vesiculation. Furthermore, we
directly correlated these molecular changes to parameters
relating to erythrocyte function in vivo by addressing
Figure 4 SMase-induced vesiculation of erythrocytes. Erythrocytes were allowed to vesiculate in the presence or absence of 10 mU/ml SMase for 1 h at 37 1C. The
vesicles were analyzed by flow cytometry. (a) Density plots of forward/sideward scatter (FSC and SSC, respectively), and Annexin V-FLUOS (PS)/anti-CD235a-PE staining of
plasma-derived vesicles and vesicles generated in vitro. Vesicles were gated according to FSC/SSC for fluorescence analysis. (b) PS and CD235a mean fluorescence
intensity (MFI), and forward scatter of plasma-derived and in vitro CD235aþ vesicles. (c) Quantification of CD235aþ vesicles after erythrocyte vesiculation in the absence or
presence of SMase. Fluorescent 10 mM counting beads were used as an internal standard. (d) Bottom left and center: density plots of CFSE-loaded erythrocytes treated with
SMase and stained with anti-CD235a-PE. The vesicles generated during the treatment of these cells were stained with anti-CD235a-PE and Annexin V-Alexa 647. Bottom
right: vesicles that were within the standard FSC/SSC vesicle range and that were positive for Annexin V are shown in the CFSE/CD235a density plot. For the assessment of
dimensions, only PSþCD235aþ vesicles were considered. Data from five healthy volunteers are presented. The graphs present mean values, error bars represent S.D., and
*Po0.05
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sensitivity to osmotic stress, permeation through a spleen-
mimicking device, and dependence on erythrocyte age.
In agreement with earlier findings,13 we observed a
reduction in cell size and increase in the percentage of PS-
exposing erythrocytes upon SMase treatment of erythrocytes.
Our time-lapse confocal microscopy experiments revealed
that the transition of their typical discoid to a spherical shape
preceded PS exposure, which was followed by disintegration
and loss of cytoplasmic content. The combination of shape
change and enhanced vesiculation explain the reduction in
size observed by flow cytometry and confocal microscopy
after SMase treatment.
Anchorage of the plasma membrane to the cytoskeleton
maintains the discoid shape and membrane stability of the
erythrocyte, as several erythrocyte disorders that affect
membrane anchorage to the cytoskeleton induce abnormal
cell shape and enhanced hemolysis.2 Similar to the observa-
tions in pathological erythrocytes, our analyses using differ-
ential membrane protein extraction demonstrated that this
anchorage is also affected by SMase. This may be mediated
by protein phosphorylation, which is known to regulate
protein–protein interactions in the erythrocyte.33 Furthermore,
membrane lipid interaction with cytoskeletal proteins might be
affected by SMase-induced membrane reorganization.34
An intriguing finding was the presence of large CFSE-
positive protein clusters that appeared in conjunction with the
detected membrane irregularities. As CFSE aspecifically
reacts with the intracellular proteins – of which 495% is
hemoglobin – the observed high-intensity CFSE signals are
most likely hemoglobin clusters. This hemoglobin clustering is
probably the indirect result of the effect of SMase on the
conformation of band 3, which has a high affinity binding site
for hemoglobin in its cytoplasmic domain.26
As shown by high-resolution, immunofluorescence micro-
scopy analysis of CD59 and stomatin localization, SMase
treatment not only led to morphological changes, but also to a
reorganization of membrane microdomains. The resulting
larger domainswere comparable in size to the endovesicle-like
structures observed with electron microscopy. Owing to their
small head group in comparison with the original phospho-
lipids, ceramides induce negative membrane curvature, which
promotes both lipid membrane invagination and blebbing.10
This provides a plausible explanation for the SMase-induced
tubular plasma membrane invaginations. Endovesicles could
result from membrane fusion in such tubular structures.35
Membrane blebbing may also further contribute to the large,
SMase-induced increase in vesiculation.27
Also, we observed ceramide-enriched membrane plat-
forms, which are known to originate in plasma membranes
with high ceramide content.8 The increase in membrane
fragility can be attributed to the formation of these large
ceramide-enriched membrane platforms, as earlier studies
revealed them to be very rigid, resulting in a weak interface
between the platform and the surrounding plasma mem-
brane.10 Small pores are known to form at this interface, which
may readily explain the loss of osmotic responsiveness of the
Figure 5 Osmotic responsiveness and fragility of SMase-treated erythrocytes. CFSE-labeled erythrocytes from three healthy volunteers were treated with increasing
activities of SMase for 15 min at 37 1C, and subsequently incubated with hypotonic, isotonic-, and hypertonic buffer for 15 min at room temperature. The cells were analyzed by
flow cytometry. A forward/sideward scatter (FSC and SSC, respectively) density plot of SMase-treated erythrocytes is shown in the upper right. A FSC/CFSE density plot of
erythrocyte subpopulation A is shown in the upper left. Forward scatter of subpopulations A and B are depicted in the bottom graphs. Populations ofo2500 cells are not shown
in the graphs. The graphs present mean values, error bars represent S.D., and *Po0.05
SMase-induced changes in erythrocyte function
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affected erythrocytes.10 Splenic sequestration of abnormal
erythrocytes with reduced deformability has been observed in
several erythrocyte disorders, and is associated with a
decreased life span and resulting hemolytic anemia in afflicted
patients.2 The presence of rigid ceramide platforms in SMase-
treated erythrocytes may lead to enhanced splenic retention.
Indeed, we could link SMase-induced ceramide formation to
reduced deformability by showing that SMase treatment
enhanced erythrocyte retention in a bead-sorting device that
mimics the mechanical deformation that erythrocytes experi-
ence in the spleen.
Vesiculation is an integral part of erythrocyte aging and
appears to constitute a protective mechanism to enhance
erythrocyte survival.27 Vesicles from erythrocyte concen-
trates were found to modulate platelet function in vitro.36
Furthermore, increased erythrocyte vesicle numbers were
observed in several disease states (e.g., chronic renal failure,
sickle cell disease, and b-thalassemia).18 SMase-induced
increase in erythrocyte vesiculation, probably resulting from a
weakening of membrane anchorage, may contribute to
disease pathology because of the pro-coagulant nature of
the vesicles.37 The presence of two distinct vesicle popula-
tions, as observed by annexin V and anti-CD235a double
staining, indicates that vesiculation occurs in distinct types of
microdomains, which are present on the erythrocyte mem-
brane during SMase treatment. Furthermore, the high CFSE
content of themicroparticles generated by treatment of CFSE-
loaded erythrocytes with SMase indicates that the micro-
particles contain a high concentration of cytoplasmic proteins.
This suggests that they are sealed vesicles containing
hemoglobin, similar to those generated in the circulation.27
This is supported by the reddish color of the vesicle pellet.
Positive-ion MALDI-TOF MS after chromatographic
separation of the total lipid extract is a very sensitive analytical
method for the detection of cell membrane ceramide content.
The observation that 1mU/ml SMase affected erythrocyte
shape, membrane organization, and osmotic responsiveness,
even though membrane ceramide content was below the
detection limit of the positive-ion MALDI-TOF MS, suggests
that erythrocytes are very sensitive to ceramide-induced
changes in membrane organization. The absence of other
non-specific breakdown products at higher enzyme activities
Figure 6 Perfusion of SMase-treated erythrocytes through a spleen-mimicking device. A suspension consisting ofB5% CFSE-labeled erythrocytes treated with SMase
for 15 min at 37 1C and 95% untreated/unlabeled erythrocytes were passed through a bead-sorting device at a flow rate of 60 ml/h (see Materials and Methods). Flow
cytometry was used to determine the percentage of labeled cells in the initial upstream compartment, the bead compartment, and the downstream fractions. Forward scatter
(FSC) is presented as a measure for erythrocyte diameter. Representative data from one of two experiments are shown
SMase-induced changes in erythrocyte function
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excludes alternative degradation processes as the basis for
these observations.
Critically ill patients, in particular those suffering from
severe inflammation and sepsis, frequently receive blood
transfusions. We showed that erythrocyte storage under
blood bank conditions increased the sensitivity to SMase. This
may reduce erythrocyte survival after transfusion, especially
in patients with enhanced SMase activity. Also, in healthy
individuals, physiological erythrocyte age is associated with
enhanced sensitivity. Therefore, cellular age likely underlies
the observed heterogeneity in susceptibility to SMase per
individual cell, as is particularly apparent in Figure S1 and
Supplementary Movie S1. These findings imply that the use of
older erythrocyte concentrates in patients suffering from
systemic inflammation might result in reduced transfusion
efficacy and a higher risk of harmful side effects, such as
extravascular hemolysis and increased plasma iron concen-
trations, which are associated with a SMase-induced rapid
clearance.38
In summary, we have shown that multiple, pathophysiolo-
gically relevant erythrocyte parameters are affected by
SMase. These parameters are associated with changes that
exceeded mere membrane lipid rearrangement and included
altered protein–protein interaction, membrane stability,
deformability, and enhanced erythrocyte vesiculation.
Furthermore, our findings suggest that enhanced SMase
secretion during chronic inflammation contributes to the
enhanced erythrocyte clearance that is often associated with
inflammation. In particular, these data suggest that transfu-
sion in patients with increased SMase activity should be
restricted to fresh erythrocyte concentrates.
Materials and Methods
Collection, isolation, and storage of erythrocytes. Fresh erythro-
cytes were isolated from whole blood (EDTA) donated by healthy human
volunteers, using Ficoll (GE Healthcare, Waukesha, WI, USA) density
centrifugation. To obtain erythrocyte populations of different age, a combination
of volume and density separation was used.27 Erythrocyte concentrates were
obtained using standard blood bank procedures. In short, whole blood (500 ml)
was collected in a Composelect quadruple CPD-SAGM top-and-bottom bag
system (Fresenius Kabi, Bad Homburg, Germany), containing 70 ml CPD as an
anticoagulant. After cooling and centrifugation, erythrocytes were isolated using a
Compomat G4 (Fresenius Kabi), after which 110 ml SAGM was added to the
erythrocytes. The erythrocyte suspension was leukocyte-depleted by in-line
filtration and subsequently stored at 2–6 1C. The study was performed following
the guidelines of the local medical ethical committee and in accordance with the
declaration of Helsinki. Written informed consent was obtained from all blood
donors participating in this study.
Solutions. Erythrocytes were kept in Ringer solution (125 mM NaCl, 5 mM KCl,
1 mM MgSO4, 32 mM HEPES, 5 mM glucose, 2.5 mM CaCl2, pH 7.4). NaCl
concentrations of 162.5 mM and 87.5 mM NaCl were used for hyper- and
hypotonic Ringer, respectively. Calcium-free Ringer was used during whole-blood
erythrocyte and vesicle isolation to prevent clotting.
Erythrocyte lysis was performed using lysis buffer (10 mM HEPES, 1 mM EDTA,
1 mM EGTA, 1 mM benzamidine, and 0.005 mM leupeptin, pH 8.0). Protein extractions
were performed using extraction buffer (25 mM HEPES, 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1 mM benzamidine, 0.005 mM leupeptin, 1% TritonX-100, pH 7.4). When
indicated, TritonX-100 was replaced by 10 mM n-Dodecyl-b-D-Maltoside (DDM).
SMase treatment. Unless mentioned otherwise, 2 106 erythrocytes were
incubated in 100ml Ringer containing various concentrations of SMase (Sigma-
Aldrich, St. Louis, MO, USA; 159 U/mg; one unit of SMase hydrolyzes 1 mM of SM
per minute at pH 7.4 at 37 1C) for 15 min at 37 1C. After treatment, cells were
washed twice with Ringer and centrifuged at 1000 g for 3 min. When treated in
the absence of extracellular calcium, cells were washed five times with calcium-
free Ringer before treatment in this buffer. Subsequent washing and staining of
cells in Ringer was performed at 4 1C.
Figure 7 SMase-induced size change and PS exposure in stored and aged erythrocytes. Flow cytometry of erythrocytes treated with SMase. Annexin V-FLUOS staining
was performed to determine the percentage of PS-exposing erythrocytes. Forward scatter is presented as a measure of erythrocyte diameter. (a) Fresh, 14, and 35 days
stored erythrocytes from six healthy donors treated with 1 mU/ml SMase for 15 min at 37 1C. (b) Erythrocytes of various mean age obtained from a 27-year-old male donor by
combined density and volumetric separation (see Materials and Methods), treated with 1 and 10 mU/ml SMase for 15 min at 37 1C. t, total erythrocyte product. Erythrocyte
fractions 1 and 5 have the lowest and highest mean age, respectively. The graphs present mean values, error bars represent S.D., and *Po0.05
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Flow cytometry. To probe PS exposure, cells were washed with Ringer
containing 0.2% bovine serum albumin (BSA, Sigma-Aldrich) and stained with
Annexin V-FLUOS (Roche, Basel, Switzerland; 1/25) for 1 h at room temperature.
Alternatively, erythrocytes were stained with 1 mM CFSE diacetate (Invitrogen,
Carlsbad, CA, USA) in Ringer for 15 min at 37 1C before SMase treatment. Excess
CFSE diacetate was removed by washing cells three times with Ringer containing
0.2% BSA. Flow cytometry was performed on a FACSCalibur system using
Cellquest Pro software version 6.0 (BD Biosciences, Franklin Lakes, NJ, USA).
Per sample, 25 000 cells were measured and data analysis was performed using
Cyan Summit software version 4.3 (Dako, Glostrup, Denmark).
Confocal microscopy. For time-lapse confocal laser scanning microscopy
experiments, 200 ml Ringer containing 1 106 CFSE diacetate-labeled erythro-
cytes, Annexin V-Alexa 647 (Roche; 1/20), and 10 mU SMase were added to a
Lab-Tek chambered coverglass (Thermo Fisher Scientific, Rochester, NY, USA).
One minute after addition of SMase to the erythrocytes, recording of images was
started with 30-sec intervals for a total of 60 min.
Mouse anti-CD59-Alexa 647 monoclonal antibody (clone MEM-43, AbD Serotec,
Du¨sseldorf, Germany; 1/200) staining was performed on erythrocytes in Ringer
buffer. Acrolein-fixated erythrocytes were used for combined antibody staining with
mouse anti-stomatin (GARP-50, kindly provided by Rainer Prohaska, University of
Vienna, Austria; 1/200) and rabbit polyclonal antiserum against the membrane
domain of human band 3 (K2N6B/PMB3;39 1/100). Acrolein fixation and subsequent
staining were performed as described by Matte et al.40 BSA (1%) was used instead
of fish skin gelatin for blocking purposes. Secondary antibodies were goat anti-
mouse-Alexa 488 and goat anti-rabbit-Alexa 633 (Invitrogen; 1/1000). Ceramide
staining on acrolein-fixated erythrocytes was performed using anti-ceramide IgM
(clone MID 15B4, Enzo life sciences, Farmingdale, NY, USA, 1/50) and isotype
control IgM (BD Biosciences, 1/50), followed by goat anti-mouse-Alexa 647 staining
(Invitrogen; 1/200).
Confocal laser scanning microscopy was performed on a TCS SP5 confocal laser
scanning microscope (Leica Microsystems, Mannheim, Germany) equipped with a
HCX Plan-Apochromat 63X/N.A. 1.2 water immersion lens. Cells were imaged at a
temperature-controlled stage set at 37 1C. The Leica TCS SP5 LAS AF software was
used for image acquisition. Image J version 1.45J (National Institutes of Health,
Bethesda, MD, USA) was used for further image analysis.
Electron microscopy. Erythrocytes were fixated with 1% glutaraldehyde in
0.1 M sodium cacodylate buffer (pH 7.2) for 1 h at room temperature. The cells
were then washed twice in cacodylate buffer and post-fixated for 1 h in 1%
osmium tetraoxide. After two more washes with cacodylate buffer, samples were
pelleted in 2% agarose (ultra-low gelling temperature, Sigma-Aldrich) and cells
were dehydrated by incubation in an ascending series of aqueous ethanol for
15 min per incubation step. Cells were then incubated overnight in ethanol and
Epon at a 1/1 ratio, subsequently incubated for 4 h in pure Epon and embedded at
37 1C overnight in fresh Epon. The samples were then stored at 60 1C overnight,
after which 80-nm sections were made using a Reichert Ultracut 6 Microtome
(Reichert, Depew, NY, USA). After drying, sections were stained in uranyl acetate
for 20 min and subsequently in lead citrate for 10 min. Sections were examined
with a JEOL TEM 1010 (JEOL Ltd, Tokyo, Japan).
Erythrocyte vesiculation. All buffers used for vesicle generation, isolation,
and analysis were complemented with 0.2% BSA and filtered (0.22mM) before
use. Erythrocytes (1 109) were incubated with 5 ml Ringer containing 10 mU/ml
SMase for 1 h. The cell suspension was centrifuged for 10 min at 1500 g, and
the supernatant was centrifuged again for 20 min at 1500 g. Vesicles were then
pelleted by centrifugation at 21 000 g and 4 1C for 20 min. The vesicles were
washed once with Ringer and resuspended in 25 ml Ringer. Vesicles from whole
blood were isolated from 200 ml plasma as described above, with an additional
calcium-free Ringer wash of the vesicle pellet after high-speed centrifugation.
Vesicles were stained with Annexin V-FLUOS and anti-CD235a-PE monoclonal
antibody (clone KC16, Beckman Coulter, Brea, CA, USA; 1/50) in a total volume of
50ml Ringer for 45 min at room temperature, and washed once with Ringer.
Vesicles were resuspended in 150ml Ringer, and washed Flow-Count Fluoro-
spheres (Beckman Coulter) were added (1 104) for quantification. Samples were
analyzed by flow cytometry as described for erythrocytes at high speed for 1 min,
using a protocol optimized for vesicle analysis. Sulfate latex microspheres
(Invitrogen; 0.9mM) were used to determine the maximum upper boundary allowed
for forward and sideward scatter gating. All staining solutions were centrifuged
at 21 000 g and 4 1C for 20 min before use to remove fluorescent aggregates.
PE-conjugated IgG1 isotype control (Dako) did not show any aspecific binding.
Membrane protein extraction, SDS-PAGE, and immunoblot.
Erythrocytes (1 109) were incubated with 5 ml Ringer containing 10 mU/ml
SMase for 1 h and subsequently lysed in 1 ml lysis buffer. The membrane fraction
was washed repeatedly by centrifugation at 21 000 g for 10 min to remove free
hemoglobin. Membrane proteins were extracted by adding 200ml extraction buffer
and samples were vortexed for 30 s. The samples were incubated for 30 min with
regular vortexing and were subsequently centrifuged at 21 000 g for 15 min.
Laemmli sample buffer (Bio-Rad, Hercules, CA, USA) containing 5% 2-mercapto-
ethanol was added to the supernatant at a 1/1 ratio (v/v). The remaining pellet was
washed once with phosphate-buffered saline (PBS, pH 7.4) and resuspended in
50ml sample buffer.
SDS-PAGE was performed using 12.5% running gels within the Mini Protean 3
system (both Bio-Rad), according to the method of Laemmli Either band 3 protein or
actin were used as loading controls. Apparent molecular masses were calculated
based on the Precision Plus Protein Standard (Bio-Rad). After SDS-PAGE, the
proteins were transferred to PVDF membranes using the iBlot system (Invitrogen).
The membranes were then blocked with Odyssey Blocking Buffer (OBB, LI-COR,
Lincoln, NE, USA), and incubated for 16 h at 4 1C in OBB containing 0.1% Tween-
20, rabbit anti-band 3 serum (K2N6B/PMB3;39 1/5000), and mouse anti-b actin
monoclonal antibody (clone AC-15, Sigma-Aldrich; 1/5000). After washing with PBS
containing 0.1% Tween-20, the blots were incubated for 1 h at room temperature in
OBB, 0.1% Tween-20, 0.01% SDS, goat anti-rabbit IgG-Alexa Fluor 680 (Invitrogen;
1/10 000), and goat anti-mouse IgG-IRDye 800 (LI-COR; 1/10 000). This final
incubation was followed by a single washing step with PBS containing 0.1% Tween-
20, and three subsequent washes with PBS. Immunoblots were scanned using the
Odyssey Infrared Imaging System (LI-COR), and analyzed using Odyssey Software
version 2.1.
Positive-ion MALDI-TOF MS and 31P NMR analyses of mem-
brane lipids. Packed erythrocytes (300ml) were incubated with 5 ml Ringer
containing SMase for 1 h and subsequently lysed and washed as described for
membrane protein extraction. Membrane pellets (200ml) were transferred to glass
tubes and 2 ml methanol and 1 ml dichloromethane were added. After vortexing,
another 1 ml dichloromethane and 1.6 ml 0.5% acetic acid were added and
vortexed once more. After 10-min centrifugation at 800 g, the bottom
dichloromethane layer was isolated. Residual lipids were extracted from the
aqueous layer by extraction with 1 ml dichloromethane. The two dichloromethane
fractions were pooled and the solvent evaporated. The lipid fraction was analyzed
by positive-ion MALDI-TOF MS and 31P NMR spectroscopy as described by
Dannenberger et al.41 Shortly, the lipid extract was mixed 1:1 (v/v) with the matrix
solution (0.5 M 2,5-dihdyroxybenzoic acid in methanol), and 1ml of this mixture
was directly applied onto the MALDI target. All MALDI-TOF mass spectra were
acquired on an Autoflex I mass spectrometer (Bruker Daltonics, Bremen,
Germany) with ion reflector. The system utilizes a pulsed 50-Hz nitrogen laser,
emitting at 337 nm. The extraction voltage was 20 kV and gated matrix
suppression was applied to prevent the saturation of the detector by matrix ions.
All spectra were acquired in the reflector mode using delayed extraction
conditions. Peak identities were additionally confirmed by recording post source
decay spectra as previously described.42 As the focus of this study is on SM, no
negative-ion spectra were acquired because SM is much more sensitively
detectable in the positive-ion mode.43
Erythrocyte bead-sorting device. Erythrocyte retention/deformability was
assessed using a bead-sorting device that mimics the mechanical deformation that
erythrocytes experience in the spleen.44 After SMase treatment, erythrocytes
(1 108) were labeled with CFSE diacetate. A 2% hematocrit suspension (600ml)
consisting of 5% treated/labeled and 95% untreated/unlabeled erythrocytes in Ringer
with 1% BSA was passed through the bead-sorting device at a flow rate of 60 ml/h.
The untreated/unlabeled erythrocytes acted as both facilitators of steady perfusion of
the cells of interest, and as an internal control for retention/deformability. Flow
cytometry measurement (1 00 000cells) of the initial upstream compartment, the
bead compartment, and downstream fractions was performed to determine the ratio
of labeled versus unlabeled erythrocytes in each separate fraction.
Statistical analysis. Differences between two groups of data were
determined using a paired ttest. Differences between multiple groups were
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assessed with a repeated measures one-way ANOVA in combination with Tukey’s
post-test. Reported P-values are two sided, and a P-value ofo0.05 was used to
assess statistical significance.
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